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Prevalence of the Polymorphism MTHFR A1298C and not 
MTHFR C677T Is Related to Chromosomal Aneuploidy in 
Brazilian Turner Syndrome Patients
ABSTRACT
Background: Dysfunctions in the folate metabolism can result in DNA hypom-
ethylation and abnormal chromosome segregation. Two common polymor-
phisms of this enzyme (C677T and A1298C) reduce its activity, but when 
associated with aneuploidy studies the results are confl icting. The objective 
of the present study is to analyze the MTHFR gene polymorphisms in women 
with Turner Syndrome and in a control group, correlating the fi ndings to the 
chromosomal aneuploidy. Methods: The study comprised 140 patients with 
Turner Syndrome, of which 36 with chromosome mosaicism and 104 non-
mosaics, and a control group of 209 fertile and healthy women without a his-
tory of any offspring with aneuploidy. Polymorphisms C677T and A1298C 
were studied by RFLP-PCR and the results were statistically analyzed. Results: 
The frequency of genotypes MTHFR 677CC, 677CT and 677TT in the patients 
with Turner Syndrome and chromosome mosaicism was, respectively, 58.3%, 
38.9% and 2.8%. Among the patients with non-mosaic Turner Syndrome, 
47.1% presented genotype 677CC, 45.2% genotype 677CT, and 7.7% genotype 
677TT. Among the 209 individuals of the control group, genotypes 677CC, 
677CT and 677TT were found at the following frequencies: 48.3%, 42.1% and 
9.6%, respectively. As for polymorphism A1298C, the patients with Turner Syn-
drome and chromosome mosaicism presented genotypes 1298AA, 1298AC 
and 1298CC at the following frequencies: 58.3%, 27.8% and 13.9%, respectively. 
Among the non-mosaic Turner Syndrome patients, genotype 1298AA was 
found in 36.5%, genotype 1298AC in 39.4%, and genotype 1298CC in 22.1%. In 
the control group, genotypes 1298AA, 1298AC and 1298CC were present at the 
following frequencies: 52.6%, 40.7% and 6.7%, respectively. Conclusion: No 
correlation was observed between the MTHFR gene polymorphism 677 and 
chromosomal aneuploidy in the Turner Syndrome patients. However, the MTH-
FR gene polymorphism at position 1298, mainly genotype 1298CC that reduces 
the enzyme effi ciency, was more frequent in the group of Turner Syndrome 
patients, suggesting its involvement in mechanisms related to chromosomal 
imbalances. (Arq Bras Endocrinol Metab 2008; 52/8:1374-1381)
Keywords: Turner syndrome; MTHFR gene; Polymorphism; Aneuploidy; 
Chromosomal imbalance
RESUMO
A Prevalência do Polimorfi smo A1298C e não do C677T do Gene MTHFR está 
Relacionada à Ocorrência de Aneuploidias Cromossômicas em Mulheres 
Brasileiras Portadoras da Síndrome de Turner.
Introdução: Disfunções no metabolismo dos folatos podem resultar em 
hipometilação do DNA e na segregação cromossômica anormal. Dois poli-
morfi smos comuns no gene MTHFR (C677T e A1298C) reduzem a atividade 
da enzima e, quando associados a estudos de aneuploidias apresentam re-
sultados confl itantes. O objetivo do presente estudo foi a análise dos poli-
morfi smos do gene MTHFR em mulheres portadoras da síndrome de Turner 
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e em indivíduos de grupo-controle, correlacionando os achados ao mecanis-
mo de formação de aneuploidias cromossômicas. Métodos: Foram estuda-
das 140 portadoras da síndrome de Turner sendo 36 com mosaicismo 
cromossômico e 104 não-mosaicos, e um grupo-controle composto por 209 
mulheres férteis e saudáveis sem história de prole com aneuplodia. Os poli-
morfi smos MTHFR C677T e A1298C foram estudados por RFLP-PCR e os re-
sultados analisados estatisticamente. Resultados: A freqüência dos genótipos 
MTHFR 677CC, 677CT e 677TT nas pacientes portadoras de síndrome de 
Turner e mosaicismo cromossômico foi, respectivamente, 58,3%, 38,9% e 
2,8%. Das pacientes portadoras de síndrome de Turner não-mosaico, 47,1% 
apresentaram o genótipo 677CC, 45,2% o genótipo 677CT e 7,7% apresen-
taram o genótipo 677TT. Nos 209 indivíduos do grupo-controle, os genótipos 
677CC, 677CT e 677TT foram encontrados nas seguintes freqüências: 48,3%, 
42,1% e 9,6%, respectivamente. Quanto ao polimorfi smo A1298C, as portado-
ras de síndrome de Turner e mosaicismo cromossômico apresentaram os 
genótipos 1298AA, 1298AC e 1298CC nas seguintes freqüências: 58,3%, 27,8% 
e 13,9%, respectivamente. Já nas portadoras de Síndrome de Turner não-
mosaico, o genótipo 1298AA foi encontrado em 36,5%, o genótipo 1298AC 
em 39,4% e o genótipo 1298 CC em 22,1% . No grupo-controle, os genótipos 
1298AA, 1298AC e 1298CC estavam presentes nas freqüências 52,6%, 40,7% 
e 6,7%. Conclusão: Não foi observada correlação entre o polimorfi smo C677T 
do gene MTHFR e a aneuploidia cromossômica presente nas portadoras de 
síndrome de Turner. O polimorfi smo A1298C do gene MTHFR, principalmente 
o genótipo 1298CC, foi mais freqüente nas portadoras de síndrome de Turner, 
sugerindo seu envolvimento no mecanismo de formação de aneuploidias 
cromossômicas. (Arq Bras Endocrinol Metab 2008; 52/8:1374-1381)
Descritores: Síndrome de Turner; Gene MTHFR; Polimorfi smo; Aneuplodia
INTRODUCTION 
Approximately 15-20% of the clinically recognized pregnancies are spontaneously aborted, most of 
them during the fi rst trimester (1). Cytogenetic studies 
of spontaneous abortions have revealed that chromoso-
me abnormalities are the main cause, contributing with 
about 50 to 60% of the cases (2,3). Sex chromosome 
monosomy is the most common chromosomal abnor-
mality in humans, occurring in about 1 to 2% of all 
pregnancies (4). The liveborn 45,X individuals present 
the clinical characteristics of the Turner Syndrome 
(TS). Some authors believe that the presence of ano-
ther sex chromosome is essential at some time of the 
embryonic life, once 99% of the 45,X conceptuses do 
not reach term (5). The high frequency of mosaicism 
makes the Turner Syndrome an anomaly of great inte-
rest in the search for clarifi cation of the nondisjunction 
mechanism.
The molecular mechanisms which determine chro-
mosomal nondisjunction are not well known so far, but 
dysfunctions in folate metabolism and methylation may 
result in DNA hypomethylation and in abnormal chro-
mosome segregation. There are data in the literature 
correlating metabolic folate defi ciency with aneuploidy 
of chromosomes 17 and 21 in human lymphocytes (6). 
Methylenetetrahydrofolate reductase (MTHFR) plays a 
crucial role in the regulation of DNA methylation. 
The MTHFR gene, located on the short arm of 
chromosome 1 (1p36.3), presents two common poly-
morphisms involving nucleotides C677T and A1298C. 
The change of C for T at position 677 causes the subs-
titution of alanine for valine in the MTHFR protein 
and the consequent reduction in enzyme activity. The 
specifi c activity of the MTHFR enzyme is reduced by 
35% in the presence of heterozygosis, genotype C/T, 
compared to the normal genotype C/C, and by 70% in 
homozygosis, genotype T/T. Polymorphism A1298C 
brings about the substitution of a glutamate for a vali-
ne, causing a reduction in the enzyme activity that is 
more effective when in homozygosis (7-10).
MTHFR catalyzes the synthesis of 5-methylte-
trahydrofolate, the main methyl donor for the reme-
thylation of homocysteine to methionine. Homocysteine 
is an amino acid formed by the demethylation of me-
thionine, an essential amino acid (Figure 1). 
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Polymorphism C677T is located within the catalytic 
domain of the protein, whereas A1298C is located wi-
thin the presumably regulatory domain. Polymorphism 
A1298C infl uences the specifi c activity of the enzyme 
and also the folate concentration, but with less impact 
than polymorphism C677T (10).
Folate is essential for the synthesis of nucleotide 
precursors (used in DNA synthesis), for the methyla-
tion reactions (7) and for the conversion of uracil 
(dUMP) to thymidylate (dTMP) (8). In the eukaryotic 
cells, about 5% of the cytosine residues are methylated 
forming 5-methylcytosine that have both a structural 
and regulatory signifi cance (9).
A reduction in the MTHFR enzyme activity requi-
res an increased folic acid intake to keep the remethyla-
tion of homocysteine into methionine normal (9). 
Consequently, low folate concentrations in individuals 
with a reduced MTHFR enzyme activity result in an 
increase in the homocysteine levels and a decrease in 
plasma methionine. Intracellular homocysteine is asso-
ciated with DNA-methyltransferase inhibition and 
DNA hypomethylation (11). 
The metabolic pathways of folate can be modifi ed 
by polymorphisms in relevant genes such as MTHFR, 
or by the action of carcinogenic elements, as for exam-
ple alcohol or tobacco (12). 
According to Santos and cols. (13), Turner syndro-
me may be an investigation model for MTHFR gene 
polymorphisms for somatic chromosomal non-disjunc-
tion, due to the high frequency of chromosome mosai-
cism in these patients. These authors studied 49 TS 
patients and 200 controls and found a high frequency 
of genotype C677T/C677T in TS patients group. 
They concluded that, when in homozygosis, this muta-
tion can have a somatic effect on chromosomal non-
disjunction through a decrease in MTHFR activity in 
TS patients.
Thus, the objective of the present study is to analyze 
polymorphisms C677T and A1298C of the MTHFR 
gene in women with Turner Syndrome with and wi-
thout chromosome mosaicism and in a control group, 
correlating the fi ndings with the origin of chromoso-
mal aneuploidy.
SUBJECTS AND METHODS
Patients and controls
Screening of the individuals was performed at the Go-
nads and Development Outpatient Clinic of the Disci-
pline of Endocrinology of Unifesp-EPM and of the 
Medical Genetics and Molecular Biology Unit of the 
General Hospital from University of Cuiaba, and a to-
tal of 140 women who were under clinical follow-up 
and had a confi rmed cytogenetic diagnosis of Turner 
Syndrome were included in the study. Of these, 36 had 
chromosome mosaicism cytogenetically detected and 
104 were non-mosaics (Table 1). The control group 
comprised blood sample of 209 fertile women in good 
health and without history of children with chromoso-
me aneuploidies from Familiar Planning Outpatient 
DNA + protein
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Figure 1. Folate cycle8.
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Clinic of the  Medicine College from ABC. The study 
protocol was approved by the local research ethics com-
mittee (CEP 1902/06). All TS patients and/or their 
parents gave informed consent for the study.
Evidencing the current trend towards an earlier 
diagnosis of TS, the reasons for seeking medical atten-
tion went from prenatal diagnosis, short stature, and 
primary amenorrhea to infertility. A hormone profi le 
consistent with hypergonadotropic hypogonadism or 
an unexplained short stature in females led to cytoge-
netic evaluation. 
Methods
Karyotypes were determined by standard cytogenetic 
analysis of peripheral blood lymphocytes, and the number 
of metaphases analyzed by G banding followed Hook’s 
(1977) (14) criteria for detecting 8% mosaicism in 40 
metaphases, with a confi dence interval of 95%. For ge-
nomic DNA extraction, peripheral blood was collected 
according to the protocol developed by Lahiri and Num-
berger (1991) (15), with modifi cations.
The primers for amplifi cation of regions 677 and 
1298 of the MTHFR gene were the following: 677F - 
(5´-TGAAGGAGAAGGTGTCTGCGGGA-3´), and 
677R - (5´-AGGACGGTGCGGTGAGAGTG-3´) (16); 
and 1298F - (5´-CAAGGAGGAGCTGCTGAAGA-3´) 
exonic primer and 1298R (5´-CAACTCCAGCAT-
CACT-3´) intronic primer (17) (Figure 2). 
PCR was performed in a fi nal reaction volume of 
50 µL containing 200 ng of genomic DNA, 10 mM of 
MgCl2, 10 mM, 2.5 U of Taq DNA polymerase (Invit-
rogen), 10 mM of Tris-HCl (pH8.4), 50 mM of KCl, 
3.0 mM of MgCl2, 0.2 µM of each primer. Amplifi ca-
tion was carried out in a thermal cycler (Perkin Elmer 
7500®) and consisted of a 5 min denaturing step at 
95ºC, followed by 35 cycles of 1 min at 95ºC (dena-
turing), 1 min of annealing at 61ºC and 1 min at 72ºC 
(extension), followed by a fi nal extension cycle of 7 min 
at 72ºC. The whole reaction product was electrophore-
sed on 1.0% agarose gel and stained with ethidium bro-
mide to verify the success of the amplifi cation.
For identifi cation of polymorphism C677T we had 
used the HinfI enzyme. Digestion with the restriction 
enzyme was carried out in a fi nal volume of 50 µL, us-
ing 30 µL of PCR product, 13.5 µL of distilled water, 
15 units of HinfI enzyme, and 5.0 µL of buffer. The 
samples were incubated for at least 3h at 37ºC. Size 
analysis of the restriction fragments was visualized after 
separation of the PCR products digested by electro-
phoresis gel containing 3% agarose and stained with 
ethidium bromide. 
For identifi cation of polymorphism A1298C we 
had used the MboII enzyme. Digestion with the restric-
tion enzyme was carried out in a fi nal volume of 50µL, 
using 30µL of PCR product, 14µL of distilled water, 
10 units of HinfI enzyme, and 5.0µL of buffer. The 
samples were incubated for at least 1h at 37ºC. Size 
analysis of the restriction fragments was visualized after 
separation of the PCR products digested by electro-
phoresis gel containing 3% agarose and stained with 
ethidium bromide. 
Polymorphism C677T creates a recognition se-
quence for the restriction enzyme HinfI, and this is de-
tected by digestion of the 198-bp PCR product, 
generating 23- and 175-bp fragments for the polymor-
phism in homozygosis (genotype TT), because the 23-
bp fragment is not retained in the gel. Genotype CC is 
characterized by the presence of a 198-bp fragment, 
and genotype CT is characterized by the presence of 
two fragments, one with 198 bp and the other with 
175 bp. 
Table 1. Karyotype and number of patients with Turner syn-
drome evaluated.
Number of Patients Karyotype
95 45,X
1 46,X,+mar
18 45,X/46,XX
1 45,X/47,XXX
5 45,X/46,X,+mar
3 45,X/46,X,i(X)(q10)
1 45,X/45,X,add(15)(p11)
2 45,X/46,X,r(X)
7 46,X,i(X)(q10)
1 45,X/46,X,idic(Yp)
1 45,X/46,XX,p+
1 45,X/46,XY
1 46,X,der(X)(p11.2)
1 46,X,der(X)/45,X
1 45,X/46,X,dup(X)(q25-q21)
Total 140
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A
CTL TT CC CT
MTHFR C677T
198 bp
175 bp
B
ACL CC AA
100 bp
72 bp
MTHFR A1298C
Figure 3. Polymorphism analysis of the methylenetetrahydrofolate reductase gene (MTHFR) amplicons by agarose gel elec-
trophoresis after restriction endonuclease digestion (RFLP). A) – ¨677 position was digested by HinfI revealing the genotypes 
CC(wild type)(198bp band), CT and TT (175bp band). B) – 1298 position was digested by MboII and presented the genotypes 
AA (wild type, 100bp band), AC and CC (72bp band).
A
677 F➝
Site Hinfl 677
5 - TGAAGGAGAAGGTGTCTGCGG ATTTCATCATCACGCAGCTTTTCTGA GCCG▼
TTGAGGCT GACACAT CGCTTTGTGAAGGCATGCACCGACATGGGCATCTCTTC▼
ACTTGCCCCATCGTCCCCGGGATCTTTCCCATCCAGgtgaggggcccaggagagcccataagctccc
677 R
Tccaccccactctcaccgcaccgtcct-3'
B
Site Mboll
Site Mboll
1298
1298 F
5' - CAAGGAGGAGCTGCT TCTGGGGG GAGGAGCTGACCAGT AGAAGA GAAGA▼
AGTGTCT TTGAAGTCTTTGTTCTTTACCTCTCGGGAGAACCAAACCGGAATGG▼
1298 R
TCACAAAgtgagtgatgctggagtgg-3'
➝
➝
➝
➝
➝
Figure 2. MTHFR gene fragment with primer sequence and 
the recognition site of the restriction enzymes used in the ex-
periment17.
There are present two sites of recognition for the 
restriction enzyme MboII in the 128-bp fragment ob-
tained by PCR that contains the 1298 region. After di-
gestion, the most common genotype, 1298AA, has 
originated three fragments (28, 28 and 72-bp) but is 
characterized just by the fragment that contains 72-bp, 
as another two were not retained in the gel.  The geno-
type CC is determined by the 100-bp alone and the AC 
genotype is determined by the presence of both frag-
ments of 72 and 100-bp in the gel (Figure 3). The re-
sults were statistically analyzed using the chi-square test.
RESULTS
The distribution of genotypes MTHFR 677CC, 677CT 
and 677TT, and of genotypes 1298AA, 1298AC and 
1298CC in Turner Syndrome patients with and wi-
thout chromosomal mosaicism and in the controls is 
shown in Table 2.
The frequency of genotypes MTHFR 677CC, 
677CT and 677TT in the patients with Turner Syn-
drome and chromosomal mosaicism was, respectively, 
58.3%, 38.9% and 2.8%. Among the patients with non-
mosaic Turner Syndrome, 47.1% presented genotype 
677CC, 45.2% genotype 677CT, and 7.7% genotype 
677TT. Among the 209 individuals of the control group, 
genotypes 677CC, 677CT and 677TT were found at 
the following frequencies: 48.3%, 42.1% and 9.6%, re-
spectively. As for polymorphism A1298C, the patients 
with Turner Syndrome and chromosomal mosaicism 
presented genotypes 1298AA, 1298AC and 1298CC at 
the following frequencies: 58.3%, 27.8% and 13.9%, re-
spectively. Among the non-mosaic Turner Syndrome 
patients, genotype 1298AA was found in 36.5%, geno-
type 1298AC in 39.4%, and genotype 1298CC in 22.1%. 
In the control group, genotypes 1298AA, 1298AC and 
1298CC were present at the following frequencies: 
52.6%, 40.7% and 6.7%, respectively. 
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There were no signifi cant differences in the geno-
type distributions considering three groups (TS patients, 
TS with somatic mosaicism and control group) for the 
677TT polymorphism. However, when compared the 
genotype frequency between the control group and TS 
patients was observed a statistical signifi cant difference 
for 1298CC genotype (p= 0.001), that was associated 
with an increased risk of aneuploidy. Considering the 
presence of both simultaneously 677TT and 1298CC, 
no statistically difference was also found.
DISCUSSION
Turner Syndrome (TS) is one of the most common 
chromosome anomalies in humans, present in 1:2500 
of female liveborns. It is characterized by short stature, 
gonadal dysgenesis, primary amenorrhea, sexual infan-
tilism, and multiple congenital anomalies (5).
A 45,X karyotype is found in 40-60% of TS patients 
(5), the others being mosaics with a 45,X cell line ac-
companied by others, with two or more X chromoso-
mes. Approximately 30% of all cases present structural 
alterations of the X chromosome  whether in homoge-
neous or in mosaic karyotypes including a 45,X cell line, 
and fi nally about 5% are accounted for by patients with 
structural alterations of the Y chromosome as well as 
mosaics, with a cell line accompanied by others which 
include at least one Y chromosome, complete or not. 
It is estimated that 15-20% of the human concep-
tuses carry chromosomal anomalies due to errors in 
meiosis which are most of the time lethal to the fetus 
(18). The mechanism most frequently involved in the 
generation of aneuploidies is chromosome nondisjunc-
tion, when the homologous chromosomes or the sister 
chromatids fail to separate. Chromosomal nondisjunc-
tion is a rare adverse event that occurs preferentially 
during oocyte maturation (meiosis I), originating ga-
metes which are nullisomic or disomic for a given chro-
mosome (19) or at the time of conception (meiosis II) 
(20,21). To data, advanced age is the only well-establi-
shed risk factor.
Besides nondisjunction, other two mechanisms can 
generate aneuploidies: anaphase delay, a delay in the 
separation of homologues or sister chromatids during 
anaphase (16); and a defect in the reactions mediated 
by methionine synthase, caused by genetic and/or diet-
related factors, leading to abnormal segregation of the 
chromosomes by an indirect effect of the DNA me-
thylation patterns in the oocytes (22).
Some studies had revealed that chromosomal mal-
segregation effects could occur due to nondisjunction, 
also in somatic cells in young women that beared a 
child with Down syndrome, suggesting the existence of 
genetic or environmental factors responsible for the 
formation of monosomic/disomic gametes (23). 
The study by James and cols. (24) was the fi rst to 
suggest an association between abnormal folate meta-
bolism and the occurrence of trisomy 21-affected preg-
nancies in a sample of young mothers. Folate and 
homocysteine metabolism can be infl uenced by genetic 
variants not only in MTHFR, but in other genes related 
to folate metabolism. However, some studies consider 
Table 2. Frequency of MTHFR gene polymorphisms C677T and A1298C detected in patients presenting Turner Syndrome with 
and without chromosome mosaicism and in the individuals of the control group. 
TS patients with 
mosaicism
TS patients without 
mosaicism
Controls
Gene polymorphism Gendtype n % n % n % p
CC 21 58,3 49 47.1 101 48.3 0.557
MTHFR 677 CT 14 38,9 47 45,2 88 42,1 0,548
TT 1 2.8 8 7.7 20 9.6 0.502
Total 36 104 209
AA 21 58.3 38 36.5 110 52.6 0,46
MTHFR 1298 AC 10 27.8 41 39.4 85 40.7 0.490
CC 5 13.9 23 22.1 14 6.7 <0.001
Total 36 104 209
Statistical signifi cance was determined at p<0,05,
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that nutritional defi ciencies in folic acid or vitamin B12 
are often necessary to detect phenotypic expression of 
these gene variants (9,25), as can be associated with 
elevated levels of plasma homocysteine. Chango and 
cols (25), studying MTHFR polymorphism on A677T 
in a French population are in accordance with some 
previous studies that could not establish a correlation 
between TT and homocysteine, suggesting that folate 
intake in France may nullify any effect of this delete-
rious genotype in the carrier. Similar results have also 
been found in an Italian study conducted by Bosco and 
cols. (26). Both studies suggested that the Mediterra-
nean diet high in folate could nullify a possible effect of 
MTHFR polymorphism on risk of chromosomal aneu-
ploidy development. These results are also consistent 
with the low frequency of neural-tube defects in both 
countries (27). 
Chronic folate defi ciency, and consequently of the 
methyl radical, has been associated with abnormal DNA 
methylation (28), non-disjunction by hypomethylation 
(7,24), DNA strand breaks, alterations in DNA recom-
bination, aberrant chromosomal segregations, and ex-
cessive incorporation of uracil in the DNA (8). There 
are studies showing that DNA hypomethylation, cau-
sed by a decrease in the folate concentration, can indu-
ce chromosome losses, probably resulting from the low 
condensation of the pericentromeric region (28).
Hobbs and cols. (7) reported that pericentromeric 
DNA methylation is of extreme importance to chro-
mosome stability and normal segregation. Stern and 
cols. (29) investigated whether the MTHFR gene mu-
tation C677T affected the genomic DNA methylation 
and found that individuals with the mutated genotype 
have a greater capacity to receive the methyl group than 
normal individuals, indicating hypomethylation in ge-
notype 677TT. DNA methylation can be used as a 
functional indicator of the folate levels, once folate 
plays a critical role in the prevention of chromosome 
breaks and DNA hypomethylation (28). 
Several studies have been published that aim to 
evaluate the role of the MTHFR polymorphisms in the 
risk of chromosomal aneuploidies, specially Down syn-
drome and the results are often confl icting, specially 
due to the small size of the samples. However, these 
studies are useful, as they can both underline particular 
associations in a defi ned population or be indicative of 
a more general potential association so that, when eva-
luating combined results produced to date, some gene-
ral information can be drawn (6).
The interaction between different polymorphisms 
may totally modify their individual effect and that some 
of those effects are different in carriers that had child 
with chromosomal aneuploidy and normal ones (30).
The present observations are in confl ict with previous 
results of the literature, studying less than 50 TS patients 
with multiple karyotype presentation (13). Some conside-
rations may be done related to the small sample of TS 
patients and the heterogeneity of the control group. We 
found no correlation between chromosomal nondisjunc-
tion in Turner Syndrome patients and the C677T poly-
morphism of the MTHFR gene. Polymorphism MTHFR 
A1298C was more frequent among the Turner Syndrome 
patients in the present study and, although it has less im-
pact on the enzyme activity than polymorphism MTHFR 
C677T, data suggests that this polymorphism contributes 
to the formation of aneuploidies. 
No correlation was observed between polymor-
phism C677T of the MTHFR gene and the chromoso-
me nondisjunction of the Turner Syndrome patients. 
Polymorphism A1298C of the MTHFR gene, mainly 
genotype 1298CC, was more frequent in the patients 
with Turner Syndrome, suggesting its involvement in 
the origin of chromosomal imbalances. 
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